메뉴 건너뛰기
Journal of Neurology
Volumn 251, Issue 3, 2004, Pages 360-
New formulation of BOTOX®: Complete antibody-induced therapy failure in hemifacial spasm [7]
Author keywords

[No Author keywords available]
Indexed keywords

BOTULINUM TOXIN A;
EID: 1642311191     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-004-0347-x     Document Type: Letter
Times cited : (29)
References (7)
  • 2
    • 0027421580 scopus 로고
    • Botulinum antibodies in dystonic patients treated with type A botulinum toxin: Frequency and significance
    • Zuber M, Sebald M, Bathien N, de Recondo J, Rondot P (1993) Botulinum antibodies in dystonic patients treated with type A botulinum toxin: Frequency and significance. Neurology 43:1715-1718
    • (1993) Neurology , vol.43 , pp. 1715-1718
    • Zuber, M.1    Sebald, M.2    Bathien, N.3    De Recondo, J.4    Rondot, P.5
  • 3
    • 0042381872 scopus 로고    scopus 로고
    • Botulinum toxin type B (NeuroBloc®) in patients with botulinum toxin type A antibody-induced therapy failure
    • Dressler D, Benecke R, Bigalke H (2003) Botulinum toxin type B (NeuroBloc®) in patients with botulinum toxin type A antibody-induced therapy failure. J Neurol 250:967-969
    • (2003) J Neurol , vol.250 , pp. 967-969
    • Dressler, D.1    Benecke, R.2    Bigalke, H.3
  • 4
    • 0345741248 scopus 로고    scopus 로고
    • Comparison of immunogenicity of old versus current BOTOX in cervical dystonia
    • Jankovic J, Ahsan J, Vuong KD (2002) Comparison of immunogenicity of old versus current BOTOX in cervical dystonia. Naunyn Schmiedebergs Arch Pharmacol 365(suppl 2):R25
    • (2002) Naunyn Schmiedebergs Arch Pharmacol , vol.365 , Issue.2 SUPPL.
    • Jankovic, J.1    Ahsan, J.2    Vuong, K.D.3
  • 5
    • 0031239673 scopus 로고    scopus 로고
    • Botulinum A toxin: Neutralizing and nonneutralizing antibodies - Therapeutic consequences
    • Goeschel H, Wohlfahrt K, Frevert J, Dengler R, Bigalke H (1997) Botulinum A toxin: Neutralizing and nonneutralizing antibodies - therapeutic consequences. Exp Neurol 147:96-102
    • (1997) Exp Neurol , vol.147 , pp. 96-102
    • Goeschel, H.1    Wohlfahrt, K.2    Frevert, J.3    Dengler, R.4    Bigalke, H.5
  • 6
    • 0007588785 scopus 로고    scopus 로고
    • Botulinum toxin therapy: Risk factors for therapy failure
    • Dressler D, Dirnberger G (2000) Botulinum toxin therapy: Risk factors for therapy failure. Mov Disord 15(suppl 2):51
    • (2000) Mov Disord , vol.15 , Issue.2 SUPPL. , pp. 51
    • Dressler, D.1    Dirnberger, G.2
  • 7
    • 0033735851 scopus 로고    scopus 로고
    • Complete secondary botulinum toxin therapy failure in blepharospasm
    • Dressler D (2000b) Complete secondary botulinum toxin therapy failure in blepharospasm. J Neurol 247:809-810
    • (2000) J Neurol , vol.247 , pp. 809-810
    • Dressler, D.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.